Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.

@article{Anastos2004TotalLC,
  title={Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.},
  author={Kathryn M Anastos and Quihu Shi and Audrey L. French and Alexandra Levine and Ruth M. Greenblatt and Carolyn R Williams and Jack Dehovitz and Robert Delapenha and Donald R Hoover},
  journal={Journal of acquired immune deficiency syndromes},
  year={2004},
  volume={35 4},
  pages={383-92}
}
BACKGROUND Total lymphocyte count (TLC) and hemoglobin level have been suggested as useful and inexpensive parameters to indicate need for HAART in settings in which CD4 cell counts are unavailable. If delayed-type hypersensitivity (DTH) response predicts clinical response in persons using highly active antiretroviral therapy (HAART), it may also prove useful in resource-poor settings. OBJECTIVE To examine whether TLC, hemoglobin, and DTH response observed prior to initiation of HAART predict… CONTINUE READING